This was the stock's second consecutive day of gains.

The once-monthly drug is still under study but could provide added convenience and another option for patients.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP-1 drugs, it targets a hormone that slows stomach emptying. Over 12 weeks, ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

To get a sense of who is truly in control of Amgen Inc. (NASDAQ:AMGN), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

A Bloomberg report has claimed even businesses which have purchased Copilot plans are struggling to convince users to make the switch, with drugmaker Amgen buying a 20,000 user plan, only to have ...

A new report suggests that Microsoft's sales division is struggling to differentiate Copilot from ChatGPT, with customers ...

Cantor Fitzgerald reaffirmed a neutral rating on Amgen, setting a $305 price target for the medical research firm. Despite ...

Thousand Oaks, California Wednesday, June 25, 2025, 13:00 Hrs [IST] ...

Retired pro football hall-of-famer Barry Sanders revealed he had a heart attack in 2024. But now he working to help other ...